Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.62	2.4	2.86	7.48	0.32
Short-Term Investments	10.43	8.29	9.99	-	-
Cash & Short-Term Investments	14.06	10.69	12.85	7.48	0.32
Cash Growth	31.44%	-16.79%	71.78%	2210.70%	-
Prepaid Expenses	0.87	0.59	0.52	0.72	-
Other Current Assets	-	-	-	-	0.14
Total Current Assets	14.93	11.29	13.37	8.2	0.47
Other Intangible Assets	0.48	0.58	0.7	0.81	0.91
Other Long-Term Assets	0.3	0.3	0.38	0.35	-
Total Assets	15.71	12.17	14.46	9.36	1.38
Accounts Payable	0.91	0.53	0.61	0.92	-
Accrued Expenses	2.68	2.45	2.32	2.43	4.99
Short-Term Debt	-	-	-	-	1.21
Current Portion of Long-Term Debt	0.6	0.6	0.6	0.6	-
Other Current Liabilities	-	-	-	0.62	1.78
Total Current Liabilities	4.18	3.58	3.53	4.58	7.99
Long-Term Debt	2.32	2.92	3.52	4.12	-
Total Liabilities	6.5	6.51	7.05	8.7	7.99
Additional Paid-In Capital	64.37	51.87	47.86	31.66	0
Retained Earnings	-55.17	-46.2	-37.52	-28.07	-6.61
Treasury Stock	-	-	-2.93	-2.93	-
Shareholders' Equity	9.2	5.66	7.41	0.66	-6.61
Total Liabilities & Equity	15.71	12.17	14.46	9.36	1.38
Total Debt	2.92	3.52	4.12	4.72	1.21
Net Cash (Debt)	11.13	7.17	8.73	2.76	-0.89
Net Cash Growth	55.25%	-17.85%	216.41%	-	-
Net Cash Per Share	2.37	7.96	43.25	104.82	-44.41
Filing Date Shares Outstanding	20.59	3.69	0.99	0.06	1
Total Common Shares Outstanding	8.95	0.99	0.4	0.06	1
Working Capital	10.75	7.7	9.84	3.62	-7.52
Book Value Per Share	1.03	5.74	18.34	11.75	-6.61
Tangible Book Value	8.72	5.08	6.7	-0.15	-7.52
Tangible Book Value Per Share	0.97	5.15	16.59	-2.71	-7.52

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q